sulfinpyrazone has been researched along with Infective Endocarditis in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, CE | 1 |
| Dewar, HA | 1 |
| Barnett, HJ | 1 |
1 review available for sulfinpyrazone and Infective Endocarditis
| Article | Year |
|---|---|
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc | 1979 |
1 other study available for sulfinpyrazone and Infective Endocarditis
| Article | Year |
|---|---|
Effect of sulphinpyrazone on the development of experimental endocardial vegetations.
Topics: Animals; Blood Platelets; Endocarditis; Endocardium; Fibrinolysis; Microscopy, Electron; Platelet Ad | 1982 |